Mouse models with physiological and behavioral differences attributable to differential plasticity of hippocampal and amygdalar neuronal networks are rare. We previously generated ataxin-2 (Atxn2) knockout mice and demonstrated that these animals lacked obvious anatomical abnormalities of the CNS, but showed marked obesity and reduced fertility. We now report on behavioral changes as a consequence of Atxn2-deficiency. Atxn2-deficiency was associated with impaired long-term potentiation (LTP) in the amygdala, but normal LTP in the hippocampus. Intact hippocampal plasticity was associated behaviorally with normal Morris Water maze testing. Impaired amygdala plasticity was associated with reduced cued and contextual fear conditioning. Conditioned taste aversion, however, was normal. In addition, knockout mice showed decreased innate fear in several tests and motor hyperactivity in open cage testing. Our results suggest that Atxn2-deficiency results in a specific set of behavioral and cellular disturbances that include motor hyperactivity and abnormal fear-related behaviors, but intact hippocampal function. This animal model may be useful for the study of anxiety disorders and should encourage studies of anxiety in patients with spinocerebellar ataxia type 2 (SCA2).
References
[1]
Burk K, Globas C, Bosch S, Graber S, Abele M, et al. (1999) Cognitive deficits in spinocerebellar ataxia 2. Brain 122 ( Pt 4): 769–77.
[2]
Burk K, Globas C, Bosch S, Klockgether T, Zuhlke C, et al. (2003) Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250L: 207–11.
[3]
Furtado S, Payami H, Lockhart PJ, Hanson M, et al. (2004) Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19: 622–629.
[4]
Le Pira F, Giuffrida S, Maci T, Marturano L, Tarantello R, et al. (2007) Dissociation between motor and cognitive impairments in SCA2: Evidence from a follow-up study. J Neurol 254: 1455–1456.
[5]
Nechiporuk T, Huynh DP, Figueroa K, Sahba S, Nechiporuk A, et al. (1998) The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression. Hum Mol Genet 7: 1301–1309.
[6]
Neuwald AF, Koonin EV (1998) Ataxin-2, global regulators of bacterial gene expression and spliceosomal snRNP proteins share a conserved domain. J Mol Med (Berlin, Germany) 76: 3–5.
[7]
Hermann T, Heumann H (1995) Determination of nucleotide distances in RNA by means of copper phenanthroline-generated hydroxyl radical cleavage pattern. 1. New York, NY: RNA. pp. 1009–1017.
[8]
Satterfield TF, Pallanck LJ (2006) Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet 15: 2523–2532.
[9]
Nonhoff U, Ralser M, Welzel F, Piccini I, Balzereit D, et al. (2007) Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 18: 1385–1396.
[10]
Shibata H, Huynh DP, Pulst SM (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum Mol Genet 9: 1303–1313.
[11]
Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol 25: 10005–10016.
[12]
Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 14: 269–276.
[13]
Huynh DP, Del Bigio MR, Ho DH, Pulst SM (1999) Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Ann Neurol 45: 232–241.
[14]
Kiehl TR, Nechiporuk A, Figueroa KP, Keating MT, Huynh DP, et al. (2006) Generation and characterization of Sca2 (ataxin-2) knockout mice. Biochem Biophys Res Comm 339: 17–24.
[15]
Lastres-Becker I, Brodesser S, Lutjohann D, Azizov M, Buchmann J, et al. (2008) Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum Mol Genet 17: 1465–1481.
[16]
Matilla A, Roberson ED, Banfi S, Morales J, Armstrong DL, et al. (1998) Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci 18: 5508–5516.
[17]
Zhang H, Das S, Li QZ, Dragatsis I, Repa J, et al. (2008) Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts. BMC Neurosci 9: 38.
[18]
Schmitt I, Linden M, Khazneh H, Evert BO, Breuer P, et al. (2007) Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem Biophys Res Comm 362: 734–739.
[19]
Anagnostaras SG, Josselyn SA, Frankland PW, Silva AJ (2000) Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. 7. Cold Spring Harbor, NY: Learning & Memory. pp. 58–72.
[20]
Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ (2006) NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. Am J Phys 291: R315–R326.
[21]
Ding HK, Teixeira CM, Frankland PW (2008) Inactivation of the anterior cingulate cortex blocks expression of remote, but not recent, conditioned taste aversion memory. 15. Cold Spring Harbor, NY: Learning & Memory. pp. 290–293.
[22]
Miranda MI, Quirarte GL, Rodriguez-Garcia G, McGaugh JL, Roozendaal B (2008) Glucocorticoids enhance taste aversion memory via actions in the insular cortex and basolateral amygdala. 15. Cold Spring Harbor, NY: Learning & Memory. pp. 468–476.
[23]
Miranda MI, Rodriguez-Garcia G, Reyes-Lopez JV, Ferry B, Ferreira G (2008) Differential effects of beta-adrenergic receptor blockade in basolateral amygdala or insular cortex on incidental and associative taste learning. Neurobiol of Learning and Memory 90: 54–61.
[24]
Yu F, Sabeti PC, Hardenbol P, Fu Q, Fry B, et al. (2005) Positive selection of a pre-expansion CAG repeat of the human SCA2 gene. PLoS Genet 1: e41.
[25]
Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, et al. (2003) The RAS effector RIN1 modulates the formation of aversive memories. J Neurosci 23: 748–757.
[26]
Shumyatsky GP, Malleret G, Shin RM, Takizawa S, Tully K, et al. (2005) Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 123: 697–709.
[27]
Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, et al. (2002) Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 111: 905–18.
[28]
Pare D, Quirk GJ, Ledoux JE (2004) New vistas on amygdala networks in conditioned fear. J Neurophys 92: 1–9.
[29]
Sigurdsson T, Doyere V, Cain CK, LeDoux JE (2007) Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharm 52: 215–227.
[30]
Goosens KA, Hobin JA, Maren S (2003) Auditory-evoked spike firing in the lateral amygdala and Pavlovian fear conditioning: mnemonic code or fear bias? Neuron 40: 1013–1022.
[31]
Dewachter I, Filipkowski RK, Priller C, Ris L, Neyton J, et al. (2009) Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol Aging 30: 241–256.
[32]
Humeau Y, Reisel D, Johnson AW, Borchardt T, Jensen V, et al. (2007) A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning. J Neurosci 27: 10947–10156.
[33]
Rogan MT, Staubli UV, LeDoux JE (1997) Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604–607.
[34]
McKernan MG, Shinnick-Gallagher P (1997) Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 30: 607–611.
[35]
King BM (2006) Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus. Am J Physiol 291: R1201–1214.
[36]
Bahar A, Dorfman N, Dudai Y (2004) Amygdalar circuits required for either consolidation or extinction of taste aversion memory are not required for reconsolidation. Euro J Neurosci 19: 1115–1118.
[37]
Al-Ramahi I, Perez AM, Lim J, Zhang M, Sorensen R, et al. (2007) dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet 3: e234.
[38]
Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, et al. (2006) ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 127: 1335–1347.
[39]
Bhalla K, Phillips HA, Crawford J, McKenzie OL, Mulley JC, et al. (2004) The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J Hum Genet 49: 308–311.
[40]
Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, et al. (2007) Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet 144B: 869–876.
